Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

6,066 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with Crizotinib.
Su Y, Long X, Song Y, Chen P, Li S, Yang H, Wu P, Wang Y, Bing Z, Cao Z, Cao L, Wu Y, Zhang Z, Liu J, Li B, Xiang J, Ma K, Zhang T, Zhang L, Mao X, Liu H, Xing P, Liang N. Su Y, et al. Among authors: cao z, cao l. Target Oncol. 2019 Apr;14(2):159-168. doi: 10.1007/s11523-019-00631-x. Target Oncol. 2019. PMID: 30895431
Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718Q.
Song Y, Jia Z, Wang Y, Wang Y, Liu P, Zhang S, Bing Z, Cao L, Cao Z, Rossi E, Zamarchi R, Denis MG, Camps C, Fernandez-Diaz AB, Liang N, Li S. Song Y, et al. Among authors: cao z, cao l. J Thorac Dis. 2020 May;12(5):2771-2780. doi: 10.21037/jtd.2020.03.29. J Thorac Dis. 2020. PMID: 32642185 Free PMC article.
6,066 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page